Overactive bladder Flashcards
what are 6 anticholinergics for overactive bladder
oxybutynin Tolterodine Fesoterodine Solifenacin Darifenacin
a lot of pts have ___ with oxybutynin IR
tolerability issues
half life of oxybutynin IR
1-3 hours
oxybutynin ADR
dizzy, confusion, somnolence
constipation
vision impairment
cognitive dysfunction, tachycardia
with oxybutynin “ “
start low dose and go slow
XL oxybutynin reaches full effect after
4 weeks
___ avoids first pass
oxbutynin patch
MOA of tolterodine
competitive muscarinic receptor antagonist
3 specific indications tolterodine
urge incontinence, urinary frequency or urgency
ADR of tolterodine
dry mouth, dyspepsia, HA, constipation, dry eyes
full effect of tolterodine at
8 wks
p450 and tolterodine
needs 2D6 and 3A4..decreased elimination with cirrhosis
what drug requires ___ reduction of dose if there is cirrhosis or ____
50%
taking a 3A4 inhibitor
answer: tolterodine
concerns for ____ in 2D6 poor metabolizers with ___med
long QT
tolterodine
___ messes up tolterodine kinetics
antacids omeprazole - leads to rapid LA release
______ med is good for renal pts who need overactive bladder tx
fesoterodine
usually for overactive bladder use ____
oxybutynin or tolterodine
fesoterodine reduces ____
daily micturitions, frequency of weekly urination and urgency episodes
ADR of fesoterodine_
dry mouth, constipation, dry eyes
____ does not require dose adjustment for mild to moderate liver or renal impairment
fesoterodine
___ is a prodrug
fesoterodine
indication of fesoterodine
alternative therapy for urge incontince, urinary frequency or urgency
___ has increased ADR in pts over 75
trospium
___ not recommended in severe renal impairment
trospium
Trospium not as effect yet 2 benefits are___
no p450 interactions good for renal pts
____ is a selective muscarinic antagonist
solifenacin
M1,2 and 3 receptors
____ is ___ protein bound
solifenacin
98%
p450 and solifenacin
CYP3A4
darifenacin has greater affininty for ___
M3 receptors
p450 and darifenacin
2D6 - no dose changes needed with inhibitors
3A4: max 7.5 mg if taking inhibitor
mirabegron is the first___
b3 agonist
mirabegron does 2 things
relaxes detrusor muscle
increases bladder capacity
concern with mirabegron
can activate beta 1 at high doses
p450 and mirabegron
CYP2D6 inhibitor - careful with metoprolol and despiramine
first line for OAB
behavioral therapy
second line OAB
antimuscarinic or b3 agonist
use XR if available
what are main OAB cautions
narrow angle glaucoma
impaired gastric emptying
urinary retention
3rd line OAB
botox injections into detrusor muscle
removes spasms and contractions